ArticleSurgical endoscopy2025
Comparison of short-term outcomes for robotic rectal surgery between the hinotori™ surgical robot system and da Vinci surgical system: a single-center retrospective study using propensity score matching analysis.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Robotic-Assisted Surgery for Colorectal Cancer Treatment in 2026: An Updated Narrative Review.Journal of clinical medicine · 2026Review
- Global Evolution of Robotic Colorectal Surgery: Lessons from Hong Kong's Innovation and Implementation.Cancers · 2026Review
- Comparative study of robot-assisted surgery for right-sided colon cancer: a propensity score-matched analysis of the hinotori Surgical Robot System and the da Vinci Surgical System.Annals of coloproctology · 2026Article
- Propensity score matched analysis of short-term outcomes in rectal cancer robotic surgery: Hugo RAS versus da Vinci systems.Journal of robotic surgery · 2026Article
- Fusion surgery in robot-assisted esophagectomy: stepwise learning curves across the da Vinci™ and hinotori™ platforms.World journal of surgical oncology · 2026Article
- Learning curve for robot-assisted rectal resection using the hinotori™ surgical robot system: a risk-adjusted cumulative sum analysis in a surgical team without prior robotic surgery experience.Journal of robotic surgery · 2026Article
- Experience with hinotoriJournal of the anus, rectum and colon · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobotic surgery for rectal cancer has grown popular in recent years and has primarily used the da Vinci Surgical System (Intuitive Surgical, CA, USA; da Vinci). In 2020, Japan introduced the hinotori™ Surgical Robot System (Medicaroid, Kobe, Japan; hinotori). We report our initial surgical experiences with robotic surgery using hinotori for rectal cancer and its feasibility and safety comparing with da Vinci.
methodsA single-institution retrospective study was conducted. Between November 2022 and November 2023, 38 and 96 patients with rectal cancer underwent robotic surgery using hinotori and da Vinci, respectively. The primary endpoint was the incidence of postoperative complications of the Clavien-Dindo classification (CD) grade ≥ II within postoperative 30 days. Secondary endpoints included surgical and console time, blood loss, conversion to other approaches, number of dissected lymph nodes, and postoperative hospital stay. A propensity score matching (PSM) analysis was used to adjust for imbalance in baseline characteristics.
resultsAfter PSM, a total of 76 patients (hinotori: 38, da Vinci: 38) were included. Compared to the da Vinci group, the hinotori group showed a similar postoperative complication rate of CD ≥ II (15.8% vs. 18.4%), comparable operative time (280.5 vs. 258 min), comparable console time (166 vs. 156 min), and less blood loss (9 vs. 17.5 mL, p = 0.025). There was no conversion in either group. The number of dissected nodes and postoperative stay were similar between the two groups.
conclusionOur findings support that robotic surgery for rectal cancer using hinotori is as safe as surgery performed using the da Vinci system.
Indexed as
Identifiers
40316750What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.